We observed a positive correlation between the serum concentrations of TNF-α and IL-1β and parameters of DM progression (glycemia and glycohemoglobin (HbA1c)) in DM patients who used CCs or HTPs (correlation coefficients were in the range of 0.066–0.849; p < 0.05). This evidence concerns the gene TNF and dermatomyositis.